Clinical use of tolerogenic dendritic cells-harmonization approach in european collaborative effort

Mediators of Inflammation

Volumn 2015, Issue , 2015, Pages

  Ten Brinke, Anja ^a   Hilkens, Catharien M U ^b   Cools, Nathalie ^c   Geissler, Edward K ^d   Hutchinson, James A ^d   Lombardi, Giovanna ^e   Lord, Phillip ^f   Sawitzki, Birgit ^g   Trzonkowski, Piotr ^h   Van Ham, S Marieke ^a   Martinez Caceres, Eva M ^h  

^a CENTRAL LABORATORY   (Netherlands)

^b NEWCASTLE UNIVERSITY   (United Kingdom)

^c Faculty of Medicine   (Belgium)

^d UNIVERSITY HOSPITAL REGENSBURG   (Germany)

^e KING'S COLLEGE LONDON   (United Kingdom)

^f NEWCASTLE UNIVERSITY   (United Kingdom)

^g MEDICAL UNIVERSITY OF GDANSK   (Poland)

^h Germans Trias i Pujol University Hospital   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; IMMUNOMODULATING AGENT;

ALLERGY; AUTOIMMUNE DISEASE; AUTOIMMUNITY; CELL THERAPY; CLINICAL PROTOCOL; CLINICAL TRIAL (TOPIC); CONSENSUS; COST; DENDRITIC CELL; DISEASE SEVERITY; DRUG MECHANISM; HUMAN; IMMUNOLOGICAL TOLERANCE; INFORMATION MODEL; MONONUCLEAR PHAGOCYTE; NONHUMAN; PRIORITY JOURNAL; RECIPIENT; REVIEW; TOLEROGENIC DENDRITIC CELL; TRANSPLANTATION; ADOPTIVE TRANSFER; COOPERATION; EUROPE; IMMUNOLOGY;

ADOPTIVE TRANSFER; AUTOIMMUNITY; CLINICAL TRIALS AS TOPIC; COOPERATIVE BEHAVIOR; DENDRITIC CELLS; EUROPE; HUMANS; IMMUNE TOLERANCE;

EID: 84954285541     PISSN: 09629351     EISSN: 14661861     Source Type: Journal    
DOI: 10.1155/2015/471719     Document Type: Review

References (39)

1. L. Brent, C. G. Brooks, P. B. Medawar, and E. Simpson, "Transplantation tolerance, " BritishMedical Bulletin, vol. 32, no. 2, pp. 101-106, 1976.
2. G. S. Cooper, M. L. K. Bynum, and E. C. Somers, "Recent insights in the epidemiology of autoimmune diseases: improved prevalence estimates and understanding of clustering of diseases, " Journal of Autoimmunity, vol. 33, no. 3-4, pp. 197-207, 2009.
3. N. Safinia, B. Afzali, K. Atalar, G. Lombardi, and R. I. Lechler, "T-cell alloimmunity and chronic allograft dysfunction, " Kidney International, vol. 78, supplement, no. 119, pp. S2-S12, 2010.
4. C. Süsal and G. Opelz, "Current role of human leukocyte antigen matching in kidney transplantation, " Current Opinion in Organ Transplantation, vol. 18, no. 4, pp. 438-444, 2013.
5. Kidney Disease: Improving Global Outcomes (KDIGO) Transplant Work Group, "KDIGO clinical practice guideline for the care of kidney transplant recipients, " American Journal of Transplantation, vol. 9, supplement 3, pp. S1-S155, 2009.
6. J. A. Hutchinson and E. K. Geissler, "Now or never? The case for cell-based immunosuppression in kidney transplantation, " Kidney International, vol. 87, no. 6, pp. 1116-1124, 2015.
7. I. V. Hutchinson, W. H. Barber, and P. J. Morris, "Specific suppression of allograft rejection by trinitrophenyl (TNP)-induced suppressor cells in recipients treated with TNP-haptenated donor alloantigens, "The Journal of Experimental Medicine, vol. 162, no. 5, pp. 1409-1420, 1985.
8. S.Qin, S. P. Cobbold, H. Pope et al., "'Infectious' transplantation tolerance, " Science, vol. 259, no. 5097, pp. 974-977, 1993.
9. P. Trzonkowski, R. Bacchetta, M. Battaglia et al., "Hurdles in therapy with regulatory T cells, " Science TranslationalMedicine, vol. 7, no. 304, p. 304ps18, 2015.
10. H. Benham, H. J. Nel, S. C. Law et al., "Citrullinated peptide dendritic cell immunotherapy in HLA risk genotype-positive rheumatoid arthritis patients, " Science Translational Medicine, vol. 7, no. 290, Article ID290ra87, 2015.
11. A. Jauregui-Amezaga, R. Cabeźon, A. Ramrez-Morros et al., "Intraperitoneal administration of autologous tolerogenic dendritic cells for refractory Crohn's disease: A phase I study, " Journal of Crohn's and Colitis, vol. 9, no. 12, pp. 1071-1078, 2015.
12. N. Giannoukakis, B. Phillips, D. Finegold, J. Harnaha, and M. Trucco, "Phase I (safety) study of autologous tolerogenic dendritic cells in type 1 diabetic patients, " Diabetes Care, vol. 34, no. 9, pp. 2026-2032, 2011.
13. J. A. Hutchinson, P. Riquelme, B. Sawitzki et al., "Cutting edge: immunological consequences and trafficking of human regulatory macrophages administered to renal transplant recipients, " Journal of Immunology, vol. 187, no. 5, pp. 2072-2078, 2011.
14. S. P. Cobbold, E. Adams, C. A. Farquhar et al., "Infectious tolerance via the consumption of essential amino acids and mTOR signaling, " Proceedings of the National Academy of Sciences of the United States of America, vol. 106, no. 29, pp. 12055-12060, 2009.
15. R. M. Steinman, "Decisions about dendritic cells: past, present, and future, " Annual Review of Immunology, vol. 30, pp. 1-22, 2012.
16. P. J. Murray and T. A. Wynn, "Protective and pathogenic functions ofmacrophage subsets, " Nature Reviews Immunology, vol. 11, no. 11, pp. 723-737, 2011.
17. A.W. Thomson and P. D. Robbins, "Tolerogenic dendritic cells for autoimmune disease and transplantation, " Annals of the Rheumatic Diseases, vol. 67, supplement 3, pp. iii90-iii96, 2008.
18. B. R. Rosborough, D. Rä?ch-Regúe, H. R. Turnquist, and A. W. Thomson, "Regulatory myeloid cells in transplantation, " Transplantation, vol. 97, no. 4, pp. 367-379, 2014.
19. P. Riquelme, E. K. Geissler, and J. A. Hutchinson, "Alternative approaches to myeloid suppressor cell therapy in transplantation: comparing regulatory macrophages to tolerogenic DCs and MDSCs, " Transplantation Research, vol. 1, no. 1, p. 17, 2012.
20. C. M. U. Hilkens, J. D. Isaacs, and A. W. Thomson, "Development of dendritic cell-based immunotherapy for autoimmunity, " International Reviews of Immunology, vol. 29, no. 2, pp. 156-183, 2010.
21. I. Van Brussel, W. P. Lee, M. Rombouts et al., "Tolerogenic dendritic cell vaccines to treat autoimmune diseases: can the unattainable dream turn into reality?" Autoimmunity Reviews, vol. 13, no. 2, pp. 138-150, 2014.
22. M. A. Boks, J. R. Kager-Groenland, M. S. P. Haasjes, J. J. Zwaginga, S. M. van Ham, and A.Ten Brinke, "IL-10-generated tolerogenic dendritic cells are optimal for functional regulatory T cell induction-A comparative study of human clinicalapplicable DC, " Clinical Immunology, vol. 142, no. 3, pp. 332-342, 2012.
23. M. Naranjo-Gomez, D. Rä?ch-Regúe, C. Oñate et al., "Comparative study of clinical grade human tolerogenic dendritic cells, " Journal of Translational Medicine, vol. 9, article 89, 2011.
24. C. van Kooten, G. Lombardi, K. A. Gelderman et al., "Dendritic cells as a tool to induce transplantation tolerance: obstacles and opportunities, " Transplantation, vol. 91, no. 1, pp. 2-7, 2011.
25. G. Amodio and S. Gregori, "Human tolerogenic DC-10: perspectives for clinical applications, " Transplantation Research, vol. 1, no. 1, article 14, 2012.
26. A. G. Thompson, B. J. O'Sullivan, H. Beamish, and R. Thomas, "T cells signaled by NF-B-dendritic cells are sensitized not anergic to subsequent activation, " Journal of Immunology, vol. 173, no. 3, pp. 1671-1680, 2004.
27. R. A. Harry, A. E. Anderson, J. D. Isaacs, and C. M. U. Hilkens, "Generation and characterisation of therapeutic tolerogenic dendritic cells for rheumatoid arthritis, " Annals of the Rheumatic Diseases, vol. 69, no. 11, pp. 2042-2050, 2010.
28. W. W. J. Unger, S. Laban, F. S. Kleijwegt, A. R. van der Slik, and B. O. Roep, "Induction of Treg by monocyte-derived DC modulated by vitamin D3 or dexamethasone: differential role for PD-L1, " European Journal of Immunology, vol. 39, no. 11, pp. 3147-3159, 2009.
29. G. B. Ferreira, A. S. Vanherwegen, G. Eelen et al., "Vitamin D3 induces tolerance in human dendritic cells by activation of intracellularmetabolic pathways, " Cell Reports, vol. 10, no. 5, pp. 711-725, 2015.
30. C. M. U. Hilkens and J. D. Isaacs, "Tolerogenic dendritic cell therapy for rheumatoid arthritis: where are we now?" Clinical and Experimental Immunology, vol. 172, no. 2, pp. 148-157, 2013.
31. A. Moreau, E. Varey, G. Beriou et al., "Tolerogenic dendritic cells and negative vaccination in transplantation: from rodents to clinical trials, " Frontiers in Immunology, vol. 3, article 218, Article ID Article 218, 2012.
32. C. Broichhausen, P. Riquelme, E. K. Geissler, and J. A. Hutchinson, "Regulatory macrophages as therapeutic targets and therapeutic agents in solid organ transplantation, " Current Opinion in Organ Transplantation, vol. 17, no. 4, pp. 332-342, 2012.
33. L.Walter, P. Riquelme, S. Tomiuk et al., "Generation of BTNL8+ inducible tregs by allogeneic human regulatory macrophages is IDO-And B7-Dependent, " American Journal of Transplantation, vol. 14, supplement 3, p. D2773, 2014.
34. Y. B. Joo, J. Park, C.Choi et al., "Phase 1 study of immunotherapy using autoantigen-loaded dendritic cells in patients with anticitrullinated peptide antigen positive rheumatoid arthritis, " in Proceedings of the ACR/ARHP Annual Meeting, Abstract 946, Boston, Mass, USA, November 2014.
35. J. A. Hutchinson, P. Riquelme, B. G. Brem-Exner et al., "Transplant acceptance-inducing cells as an immune-conditioning therapy in renal transplantation, " Transplant International, vol. 21, no. 8, pp. 728-741, 2008.
36. J. A. Hutchinson, F. Gövert, P. Riquelme et al., "Administration of donor-derived transplant acceptance-inducing cells to the recipients of renal transplants from deceased donors is technically feasible, " Clinical Transplantation, vol. 23, no. 1, pp. 140-145, 2009.
37. E. K. Geissler, "The ONE study compares cell therapy products in organ transplantation: introduction to a review series on suppressive monocyte-derived cells, " Transplantation Research, vol. 1, no. 1, article 11, 2012.
38. Commission European, "Regulation (EC) No 1394/2007 of the European Parliament and of the Council on advanced therapy medicinal products and amending Directive 2001/83/EC and Regulation (EC) No 726/2004, " Report from the Commission to the European Parliament and the Council in accordance with Article 25, European Commission, Brussels, Belgium, 28.3.2014 COM(2014) 188 final (2014).
39. A.Ten Brinke, I. Joosten, S. M. van Ham, C. van Kooten, and B. J. Prakken, "Redefining strategies to introduce toleranceinducing cellular therapy in human beings to combat autoimmunity and transplantation reactions, " Frontiers in Immunology, vol. 5, article 392, 2014.